QR Pharma Awarded SBIR Grant by NIA/NIH to Test Posiphen® and Metabolites in Various Models Read more here
Read More
Phoenix S&T Announces Expanded Availability of Capillary LC Column Heaters and Controllers in US and EU Read more here
Read More
InfrascannerTM Handheld Brain Scanner Gets $2M-Addresses Top Cause of Combat Death Read more here
Read More
Expert: Avid Could Launch Alzheimer's Agent Ahead of GE, Bayer Read more here
Read More
Promise Seen for Detecting Alzheimer's (Avid Radiopharmaceuticals) Read more here
Read More
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen® and Parkinson's Disease Read more here
Read More
Entrepreneur OnRamp Helps Dozens of New Life Science Focused Startups Read more here
Read More
QR Pharma Receives US Patent 7,625,942 to Treat Down Syndrome Read more here
Read More
QR Pharma Initiates Clinical Trial for Cognitively Impaired Patients Read more here
Read More
Treventis Scientific Founder Named 2009 Recipient of Prix Galien Canada Award for Alzheimer’s Disease Read more here
Read More
BioAdvance Expands Team to Support Portfolio and Future Investments Read more here
Read More
BioAdvance Funds Treventis to Advance Alzheimer's Drug Discovery Read more here
Read More
BioAdvance Names Dr. Philip P. Gerbino Chair and Elects Dr. John M. Daly to Board of Directors Read more here
Read More
QR Pharma Inc. Exclusively Licenses Clinical Stage Compounds Posiphen®, Bisnorcymserine and Phenserine to Treat Alzheimer’s Disease Read more here
Read More
TorreyPines Therapeutics Licenses Posiphen®, Bisnorcymcerine and Phenserine to QR Pharma Read more here
Read More
Jenrin Discovery’s Non-Brain Penetrant Cb1 Antagonists Show Beneficial Effects in Treating Diabetes and Obesity Read more here
Read More
InfraScan Launches International Sales of a Handheld Brain Hematoma Detector Read more here
Read More